Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-25

Clinical Trial Update: Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing paroxetine to placebo for secondary prevention in subthreshold PTSD; study completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: Durham VA Medical Center | Conditions: Stress Disorders, Post-Traumatic | Phase 4 | Status: COMPLETED | Results posted: 2011-01-25